Biological responses to spider silk-antibiotic fusion protein

Journal of Tissue Engineering and Regenerative Medicine

Volumn 6, Issue 5, 2012, Pages 356-368

  Gomes, Sílvia ^a,b   Gallego Llamas, Jabier ^b   Leonor, Isabel B ^a   Mano, João F ^a   Reis, Rui L ^a   Kaplan, David L ^b  

^a UNIVERSITY OF MINHO   (Portugal)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Antimicrobial activity; Chimeric protein; Hepcidin; Inflammatory response; Spider silk; Tissue engineering

Indexed keywords

ANTIBIOTICS; BIOCOMPATIBILITY; FILMS; MICROORGANISMS; TISSUE; TISSUE ENGINEERING;

ANTI-MICROBIAL ACTIVITY; BIOLOGICAL RESPONSE; CHIMERIC PROTEINS; FUSION PROTEINS; HEPCIDIN; IN-VIVO; INFLAMMATORY RESPONSE; MATERIAL SCIENCE; SPIDER SILKS; TISSUES ENGINEERINGS;

PROTEINS;

CD14 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; DRAGLINE HEPCIDIN FUSION PROTEIN; HYBRID PROTEIN; INTERLEUKIN 2 RECEPTOR ALPHA; POLYGLACTIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HISTOLOGY; IMPLANT; IMPLANTATION; INFLAMMATORY CELL; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SILK;

EID: 84859969334     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.437     Document Type: Article

References (79)

1. Aarbiou J, Ertmann M, Wetering S, et al. 2002; Human neutrophil defensins induce lung epithelial cell proliferation in vitro. J Leukoc Biol 72: 167-174.
2. Aarbiou J, Verhoosel RM, Wetering Sv, et al. 2004; Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro. Am J Respir Cell Mol Biol 30: 193-201.
3. Alba-Loureiro TC, Munhoz CD, Martins JO, et al. 2007; Neutrophil function and metabolism in individuals with diabetes mellitus. Braz J Med Biol Res 40: 1037-1044.
4. Allmeling C, Jokuszies A, Reimers K, et al. 2008; Spider silk fibres in artificial nerve constructs promote peripheral nerve regeneration. Cell Prolif 41: 408-420.
5. Allmeling C, Jokuszies A, Reimers K, et al. 2006; Use of spider silk fibres as an innovative material in a biocompatible artificial nerve conduit. J Cell Mol Med 10: 770-777.
6. Amersfoort ESV, Berkel TJCV, Kuiper J. 2003; Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 16: 379-414.
7. Bai L, Zhu L, Min S, et al. 2008; Surface modification and properties of Bombyx mori silk fibroin films by antimicrobial peptide. Appl Surf Sci 254: 2988-2995.
8. Bala I, Hariharan S, Kumar MN. 2004; PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carrier Syst 21: 387-422.
9. Bals R. 2000; Epithelial antimicrobial peptides in host defense against infection. Respir Res 1: 141-150.
10. Baoyong L, Jian Z, Denglong C, et al. 2010; Evaluation of a new type of wound dressing made from recombinant spider silk protein using rat models. Burns 36: 891-896.
11. Beek JD, Hess S, Vollrath F, et al. 2002; The molecular structure of spider dragline silk: folding and orientation of the protein backbone. Proc Natl Acad Sci USA 99: 10266-10271.
12. + T cells Curr Opin Immunol 7: 367-374.
13. Bessa PC, Balmayor ER, Azevedo HS, et al. 2010; Silk fibroin microparticles as carriers for delivery of human recombinant BMPs. Physical characterization and drug release. J Tissue Eng Regen Med 4: 349-345.
14. Beutner R, Michael J, Schwenzer B, et al. 2010; Biological nano-functionalization of titanium-based biomaterial surfaces: a flexible toolbox. J Roy Soc Interface 7: S93-105.
15. Bini E, Foo CWP, Huang J, et al. 2006; RGD-functionalized bioengineered spider dragline silk biomaterial. Biomacromolecules 7: 3139-3145.
16. Bowers K, Pitcher C, Marsh M. 1997; CD4: a co-receptor in the immune response and HIV infection. Int J Biochem Cell Biol 29: 871-875.
17. Campoccia D, Montanaro L, Speziale P, et al. 2010; Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use. Biomaterials 31: 6363-6377.
18. +T lymphocytes in normal pregnancies. Mol Hum Reprod 8: 667-673.
19. Chavakis T, Cines DB, Rhee J-S, et al. 2004; Regulation of neovascularization by human neutrophil peptides (α-defensins): a link between inflammation and angiogenesis. FASEB J 18: 1306-1308.
20. Chung HJ, Park TG. 2007; Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. Adv Drug Deliv Rev 59: 249-262.
21. Clevers H, Alarcon B, Wileman T, et al. 1988; The T cell receptor/CD3 complex: a dynamic protein ensemble. Annu Rev Immunol 6: 629-662.
22. Falzacappa MVV, Muckenthaler MU. 2005; Hepcidin: iron-hormone and anti-microbial peptide. Gene 364: 37-44.
23. Ganz T. 2003; Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102: 783-788.
24. Ganz T. 2006; Hepcidin and its role in regulating systemic iron metabolism. Hematol Am Soc Hematol Educ Program 507: 29-35.
25. Gomes S, Leonor IB, Mano JF, et al. 2010; Spider silk-bone sialoprotein as a novel fusion protein for bone tissue engineering. Soft Matter 7: 4964-4973.
26. Gomes S, Leonor IB, Mano JF, et al. 2011; Antimicrobial functionalized genetically engineered spider silk. Biomaterials 32(18): 4255-4266.
27. Grigat J, Soruri A, Forssmann U, et al. 2007; Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human α-defensin family. J Immunol 179: 3958-3965.
28. Hardy JG, Scheibel TR. 2009; Silk-inspired polymers and proteins. Biochem Soc Trans 37: 677-681.
29. Haskó G, Pacher P, Deitch EA, et al. 2007; Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol Ther 113: 264-275.
30. Hayashi CY, Shipley NH, Lewis RV. 1999; Hypotheses that correlate the sequence, structure, and mechanical properties of spider silk proteins. Int J Biol Macromol 24: 271-275.
31. Heim M, Römer L, Scheibel T. 2010; Hierarchical structures made of proteins. The complex architecture of spider webs and their constituent silk proteins. Chem Soc Rev 39: 156-164.
32. Hiemstra PS. 2006; Defensins and cathelicidins in inflammatory lung disease: beyond antimicrobial activity. Biochem Soc Trans 34: 276-278.
33. Huang J, Valluzzi R, Bini E, et al. 2003; Cloning, expression, and assembly of sericin-like protein. J Biol Chem 278: 46117-46123.
34. Huang J, Wong C, George A, et al. 2007; The effect of genetically engineered spider silk-dentin matrix protein 1 chimeric protein on hydroxyapatite nucleation. Biomaterials 28: 2358-2367.
35. Hubbell JA. 2003; Materials as morphogenetic guides in tissue engineering. Curr Opin Biotechnol 14: 551-558.
36. Janeway CA. 1992; The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu Rev Immunol 10: 645-674.
37. Janmey PA, Winer JP, Weisel JW. 2008; Fibrin gels and their clinical and bioengineering applications. J R Soc Interface 6: 1-10.
38. Jenkins MR, Griffiths GM. 2010; The synapse and cytolytic machinery of cytotoxic T cells. Curr Opin Immunol 22: 308-313.
39. Kilian O, Hossain H, Flesch I, et al. 2008; Elution kinetics, antimicrobial efficacy, and degradation and microvasculature of a new gentamicin-loaded collagen fleece. J Biomed Mater Res B Appl Biomater 90B: 210-222.
40. Kirker-Head C, Karageorgiou, Hofmann S, et al. 2007; BMP-silk composite matrices heal critically sized femoral defects. Bone 41: 247-255.
41. Koliaraki V, Marinou M, Samiotaki M, et al. 2008; Iron regulatory and bactericidal properties of human recombinant hepcidin expressed in Pichia pastori. Biochimie 90: 726-735.
42. Krause A, Neitz S, Mägert H, et al. 2000; LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobialctivity. FEBS Lett 480: 147-150.
43. Kuijpers AJ, Wachem PBv, Luyn MJAv, et al. 2000; In vitro and in vivo evaluation of gelatin-chondroitin sulphate hydrogels for controlled release of antibacterial proteins. Biomaterials 21: 1763-1772.
44. Kuijpers AJ, Wachem PBv, Luyn MJAv, et al. 2000; In vivo and in vitro release of lysozyme from cross-linked gelatin hydrogels: a model system for the delivery of antibacterial proteins from prosthetic heart valves. J Control Release 67: 323-336.
45. Langer R, Tirrell DA. 2004; Designing materials for biology and medicine. Nature 428: 487-492.
46. LeBien TW, Tedder TF. 2008; B lymphocytes: how they develop and function. Blood1121570-1580.
47. Lü J-M, Wang X, Marin-Muller C, et al. 2009; Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn 9: 325-341.
48. Mahoney DV, Vezie DL, Eby RK, et al. 1997; Aspects of the morphology of dragline silk of Nephila clavipes. In Silk Polymers, Kaplan D, Adams WW, Farmer B, Viney C (eds). American Chemical Society: Charlottesville, VA, USA; 196-210.
49. Meinel L, Hofmann S, Karageorgiou V, et al. 2005; The inflammatory responses to silk films in vitro and in vivo. Biomaterials 26: 147-155.
50. Mishra N, Goyal AK, Khatri K, et al. 2008; Biodegradable polymer based particulate carrier(s) for the delivery of proteins and peptides. Curr Med Chem Anti-inflamm Anti Allergy Agents 7: 240-251.
51. Murphy CJ, Foster BA, Mannis MJ, et al. 1993; Defensins are mitogenic for epithelial cells and fibroblasts. J Cell Physiol 155: 408-413.
52. Nemeth E, Rivera S, Gabayan V, et al. 2004; IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113: 1271-1276.
53. Nemeth E, Valore EV, Territo M, et al. 2003; Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101: 2461-2463.
54. Numata K, Hamasaki J, Subramanian B, et al. 2010; Gene delivery mediated by recombinant silk proteins containing cationic and cell binding motifs. J Control Release 146: 136-143.
55. Omenetto FG, Kaplan DL. 2010; New opportunities for an ancient material. Science 329: 528-531.
56. Pabbruwe MB, Kafienah W, Tarlton JF, et al. 2010; Repair of meniscal cartilage white zone tears using a stem cell/collagen scaffold implant. Biomaterials 31: 2583-2591.
57. Park CH, Valore EV, Waring AJ, et al. 2001; Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276: 7806-7810.
58. Park IS, Kim SH, Kim YH, et al. 2009; A collagen/smooth muscle cell-incorporated elastic scaffold for tissue-engineered vascular grafts. J Biomater Sci Polym Ed 20: 1645-1660.
59. Pigeon C, Ilyin G, Courselaud B, et al. 2001; A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 16: 7811-7819.
60. Rabotyagova O, Cebe P, Kaplan DL. 2009; Self-assembly of genetically engineered spider silk block copolymers. Biomacromolecules 10: 229-236.
61. Rohde H, Frankenberger S, Zähringer U, et al. 2010; Structure, function and contribution of polysaccharide intercellular adhesin (PIA) to Staphylococcus epidermidis biofilm formation and pathogenesis of biomaterial-associated infections. Eur J Cell Biol 89: 103-111.
62. Romano NH, Sengupta D, Chung C, et al. 2010; Protein-engineered biomaterials: nanoscale mimics of the extracellular matrix. Biochim Biophys Acta 1810: 339-349.
63. Ruiz JH, Becker I. 2007; CD8 cytotoxic T cells in cutaneous leishmaniasis. Parasite Immunol 29: 671-678.
64. Scheibel T. 2004; Spider silks: recombinant synthesis, assembly, spinning, and engineering of synthetic proteins. Microb Cell Fact 3: 14-24.
65. Schierholz JM, Beuth J. 2002; Implant infections: a haven for opportunistic bacteria. J Hosp Infect 49: 87-93.
66. Schütt C. 1999; CD14. Int J Biochem Cell Biol 31: 545-549.
67. Singh PK, Parsek MR, Greenberg EP, et al. 2002; A component of innate immunity prevents bacterial biofilm development. Nature 417: 552-555.
68. Spiess K, Lammel A, Scheibel T. 2010; Recombinant spider silk proteins for applications in biomaterial. Macromol Biosci 10: 998-1007.
69. Sponner A, Vater W, Monajembashi S, et al. 2007; Composition and hierarchical organisation of a spider silk. PLoS ONE 2: e998.
70. Tang QO, Shakib K, Heliotis M, et al. 2009; TGF-β3: a potential biological therapy for enhancing chondrogenesis. Expert Opin Biol Ther 9: 689-701.
71. Tecle T, Tripathi S, Hartshorn KL. 2010; Review: defensins and cathelicidins in lung immunity. Innate Immun 16: 151-159.
72. Vyoral D, Petrák J. 2005; Hepcidin: a direct link between iron metabolism and immunity. Int J Biochem Cell Biol 37: 1768-1773.
73. Wallace DF, Jones MD, Pedersen P, et al. 2006; Purification and partial characterisation of recombinant human hepcidin. Biochimie 88: 31-37.
74. Widhe M, Bysell H, Nystedt S, et al. 2010; Recombinant spider silk as matrices for cell culture. Biomaterials 31(6): 9575-9585.
75. Xiaa X-X, Qiana Z-G, Ki CS, et al. 2010; Native-sized recombinant spider silk protein produced in metabolically engineered Escherichia coli results in a strong fiber. Proc Natl Acad Sci USA 107: 14059-14063.
76. Xu M, Lewis RV. 1990; Structure of a protein superfiber: spider dragline silk. Proc Natl Acad Sci USA 87: 7120-7124.
77. Yan S-Z, Beeler JA, Chen Y, et al. 2001; The regulation of type 7 adenylyl cyclase by its C1b region and Escherichia coli peptidylprolyl isomerase, SlyD. J Biol Chem 276: 8500-8506.
78. Zhang H, Yuan Q, Zhu Y, et al. 2005; Expression and preparation of recombinant hepcidin in Escherichia coli. Protein Expr Purif 41: 409-416.
79. Zhu J, Paul WE. 2010; Heterogeneity and plasticity of T helper cells. Cell Res 20: 4-12.